Pages that link to "Q64857603"
Jump to navigation
Jump to search
The following pages link to Rudy J Castellani (Q64857603):
Displaying 50 items.
- Widespread distribution of reticulon-3 in various neurodegenerative diseases (Q24610758) (← links)
- Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis (Q24646892) (← links)
- A novel human disease with abnormal prion protein sensitive to protease (Q24648865) (← links)
- Prion disease and Alzheimer's disease: pathogenic overlap (Q28266468) (← links)
- Chronic effects of mild neurotrauma: putting the cart before the horse? (Q28394156) (← links)
- Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage (Q28575299) (← links)
- Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice (Q30362093) (← links)
- Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure (Q33506647) (← links)
- Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease (Q34003234) (← links)
- Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta (Q34009618) (← links)
- Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis (Q34112184) (← links)
- Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. (Q34130385) (← links)
- Treatment advances in Alzheimer's disease based on the oxidative stress model (Q34167375) (← links)
- Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease (Q34207080) (← links)
- Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease (Q34302095) (← links)
- Involvement of oxidative stress in Alzheimer disease (Q34545547) (← links)
- Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis (Q34666831) (← links)
- Iron: A Pathological Mediator of Alzheimer Disease? (Q34894011) (← links)
- CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease (Q34953854) (← links)
- Role of mitochondrial dysfunction in Alzheimer's disease (Q34976262) (← links)
- Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau (Q35004256) (← links)
- Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease (Q35061960) (← links)
- The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies (Q35065983) (← links)
- Frontiers in Alzheimer's disease therapeutics (Q35086876) (← links)
- Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease (Q35101151) (← links)
- Familial primary progressive aphasia (Q35148693) (← links)
- Simultaneous onset of Alzheimer's disease in a husband and wife in their mid-fifties: what do we really know about environmental factors? (Q35338214) (← links)
- Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover (Q35711947) (← links)
- Microtubule Reduction in Alzheimer's Disease and Aging Is Independent of τ Filament Formation (Q35749171) (← links)
- Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis (Q35789636) (← links)
- Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease (Q35824948) (← links)
- Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? (Q36135513) (← links)
- A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules (Q36190490) (← links)
- Oxidative stress and neurodegeneration (Q36203957) (← links)
- Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts (Q36204722) (← links)
- Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. (Q36458314) (← links)
- Neuropathology of Alzheimer disease: pathognomonic but not pathogenic (Q36485646) (← links)
- Malignant glioma progression and nitric oxide (Q36592874) (← links)
- Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy (Q36766849) (← links)
- Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? (Q36817040) (← links)
- Iron: the Redox-active center of oxidative stress in Alzheimer disease (Q36824768) (← links)
- Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease (Q36900007) (← links)
- Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease (Q36932516) (← links)
- Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes (Q36979395) (← links)
- Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease (Q37007594) (← links)
- The role of novel chitin-like polysaccharides in Alzheimer disease (Q37059465) (← links)
- Sublethal RNA oxidation as a mechanism for neurodegenerative disease (Q37083453) (← links)
- Current approaches in the treatment of Alzheimer's disease (Q37136865) (← links)
- The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse (Q37150786) (← links)
- Sulfonylurea receptor 1 expression in human cerebral infarcts (Q37167025) (← links)